Qube Research & Technologies (QRT)
RMD icon

Qube Research & Technologies (QRT)’s ResMed RMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$120K – 4030
2025
Q4 		$120K Sell
500
-3,900
-89% -$997K ﹤0.01% 3159
2025
Q3 		$1.2M Buy
4,400
+400
+10% +$109K ﹤0.01% 2437
2025
Q2 		$1.03M Buy
4,000
+3,000
+300% +$716K ﹤0.01% 2443
2025
Q1 		$224K Buy
1,000
+800
+400% +$187K ﹤0.01% 2834
2024
Q4 		$45.7K Hold
200
– – ﹤0.01% 3105
2024
Q3 		$48.8K Buy
+200
New +$44.7K ﹤0.01% 2866
2024
Q1 		– Sell
-1,100
Closed -$189K – 4816
2023
Q4 		$189K Buy
+1,100
New +$169K ﹤0.01% 2809

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RMD Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of ResMed (RMD) in Q4 2025, closing a stake of 142,863 shares — an estimated $36.5M sold.

Qube Research & Technologies (QRT) first reported a position in RMD in Q2 2018 and held it in 19 quarters. The position peaked at $82.6M in Q2 2023. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 142,863 ResMed shares in Q4 2025, an estimated $36.5M.
  • Qube Research & Technologies (QRT) first reported a position in ResMed in Q2 2018 and held it in 19 quarters.
  • Qube Research & Technologies (QRT)'s ResMed position peaked at $82.6M in Q2 2023.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.